SF3B1 and myelodysplastic syndrome: Mice expressing heterozygous and hematopoietic-restricted SF3B1 K700E mutation do not develop leukemia but exhibit macrocytic anemia due to a block in terminal erythroid maturation, erythroid dysplasia, and long-term hematopoietic stem cell expansion, all of which are characteristic features of MDS [15].